Childhood cancer and the Jehovah's Witness faith. (åpner nytt vindu)

Frankel LS, Damme CJ, Eys JV.

Kilde‎: Pediatrics 1977;60(6):916-21.

Arkiv‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (åpner nytt vindu)

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (åpner nytt vindu)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Kilde‎: J Clin Oncol 2014;32(27):3021-32.

Arkiv‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (åpner nytt vindu)

Red blood cell transfusion and outcome in cancer. (åpner nytt vindu)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Kilde‎: Transfus Apher Sci 2017;56(3):287-90.

Arkiv‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (åpner nytt vindu)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (åpner nytt vindu)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Kilde‎: Support Care Cancer 2010;18(10):1341-6.

Arkiv‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (åpner nytt vindu)